Literature DB >> 4640943

Improvement in myocardial function and coronary blood flow in ischemic myocardium after mannitol.

J T Willerson, W J Powell, T E Guiney, J J Stark, C A Sanders, A Leaf.   

Abstract

The purpose of this study was to evaluate the effect of hyperosmolality on the performance of, and the collateral blood flow to, ischemic myocardium. The myocardial response to mannitol, a hyperosmolar agent which remains extracellular, was evaluated in anesthetized dogs. Mannitol was infused into the aortic roots of 31 isovolumic hearts and of 15 dogs on right heart bypass, before and during ischemia. Myocardial ischemia was produced by temporary ligation of either the proximal or mid-left anterior descending coronary artery. Mannitol significantly improved the depressed ventricular function curves which occurred with left anterior descending coronary artery occlusion. Mannitol also significantly lessened the S-T segment elevation (epicardial electrocardiogram) occurring during myocardial ischemia in the isovolumic hearts and this reduction was associated with significant increases in total coronary blood flow (P < 0.005) and with increased collateral coronary blood flow to the ischemia area (P < 0.005).THUS, INCREASES IN SERUM OSMOLALITY PRODUCED BY MANNITOL RESULT IN THE FOLLOWING BENEFICIAL CHANGES DURING MYOCARDIAL ISCHEMIA: (a) improved myocardial function, (b) reduced S-T segment elevation, (c) increased total coronary blood flow, and (d) increased collateral coronary blood flow.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4640943      PMCID: PMC332981          DOI: 10.1172/JCI107126

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  15 in total

1.  ELECTROLYTE ALTERATIONS IN ACUTE MYOCARDIAL ISCHEMIC INJURY.

Authors:  R B JENNINGS; H M SOMMERS; J P KALTENBACH; J J WEST
Journal:  Circ Res       Date:  1964-03       Impact factor: 17.367

2.  Influence of osmolarity of perfusate on contractility of mammalian myocardium.

Authors:  J KOCH-WESER
Journal:  Am J Physiol       Date:  1963-06

3.  Myocardial blood flow determined with krypton 85 in unanesthetized dogs.

Authors:  J A HERD; M HOLLENBERG; G D THORBURN; H H KOPALD; A C BARGER
Journal:  Am J Physiol       Date:  1962-07

4.  Polarographic oxygen, the epicardial electrocardiogram and muscle contraction in experimental acute regional ischemia of the left ventricle.

Authors:  J J SAYEN; W F SHELDON; G PEIRCE; P T KUO
Journal:  Circ Res       Date:  1958-11       Impact factor: 17.367

5.  Cerebral ischemia. II. The no-reflow phenomenon.

Authors:  A Ames; R L Wright; M Kowada; J M Thurston; G Majno
Journal:  Am J Pathol       Date:  1968-02       Impact factor: 4.307

6.  Regulation of intracellular fluid volume and disease.

Authors:  A Leaf
Journal:  Am J Med       Date:  1970-09       Impact factor: 4.965

7.  Factors influencing infarct size following experimental coronary artery occlusions.

Authors:  P R Maroko; J K Kjekshus; B E Sobel; T Watanabe; J W Covell; J Ross; E Braunwald
Journal:  Circulation       Date:  1971-01       Impact factor: 29.690

8.  Cardiac muscle mechanics in hyperosmotic solutions.

Authors:  K Wildenthal; C L Skelton; H N Coleman
Journal:  Am J Physiol       Date:  1969-07

9.  Experimental prevention of cerebral vasculature obstruction produced by ischemia.

Authors:  R C Cantu; A Ames
Journal:  J Neurosurg       Date:  1969-01       Impact factor: 5.115

10.  Temporary coronary occlusion in conscious dogs: collateral flow and electrocardiogram.

Authors:  J E Chimoskey; M Szentivanyi; R Zakheim; A C Barger
Journal:  Am J Physiol       Date:  1967-05
View more
  22 in total

1.  The effects of hyperosmolal coronary perfusion on the haemodynamic, metabolic and ultrastructural changes of myocardial anoxia.

Authors:  N Brachfeld; J Christodoulou; R Erlandson; C Smithen
Journal:  Postgrad Med J       Date:  1975-05       Impact factor: 2.401

2.  [Histochemical and histoenzymatic study of experimental myocardial infarction in the rat by temporary and permanent ligation of the left coronary artery (author's transl)].

Authors:  J P Camilleri; J N Fabiani; A Deloche; C Gurdjian
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1975

3.  The role of cellular swelling in the pathogenesis of organ ischemia.

Authors:  R L Jamison
Journal:  West J Med       Date:  1974-03

4.  Enhanced utilization of exogenous glucose improves cardiac function in hypoxic rabbit ventricle without increasing total glycolytic flux.

Authors:  E M Runnman; S T Lamp; J N Weiss
Journal:  J Clin Invest       Date:  1990-10       Impact factor: 14.808

Review 5.  Cell volume regulation and ischemic tissue damage.

Authors:  J Flores; D R DiBona; N Frega; A Leaf
Journal:  J Membr Biol       Date:  1972-12-29       Impact factor: 1.843

6.  Hypertonic mannitol in the therapy of the acute respiratory distress syndrome.

Authors:  S R Powers; D Shah; D Ryon; J Newell; C Ralph; W Scovill; R Dutton
Journal:  Ann Surg       Date:  1977-06       Impact factor: 12.969

7.  Reperfusion after acute coronary occlusion in dogs impairs endothelium-dependent relaxation to acetylcholine and augments contractile reactivity in vitro.

Authors:  K M VanBenthuysen; I F McMurtry; L D Horwitz
Journal:  J Clin Invest       Date:  1987-01       Impact factor: 14.808

8.  Microcirculatory changes following early reperfusion in experimental myocardial infarction.

Authors:  J P Camilleri; D Joseph; J N Fabiani; A Deloche; M Schlumberger; J Relland; A Carpentier
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1976-03-05

9.  Dynamics of glomerular ultrafiltration in the rat. V. Response to ischemic injury.

Authors:  T M Daugharty; I F Ueki; P F Mercer; B M Brenner
Journal:  J Clin Invest       Date:  1974-01       Impact factor: 14.808

10.  The influence of myocardial edema formation on the energy consumption of the heart during aerobiosis and hypoxia.

Authors:  H Kahles; V A Mezger; G Hellige; P G Spieckermann; H J Bretschneider
Journal:  Basic Res Cardiol       Date:  1982 Mar-Apr       Impact factor: 17.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.